Mark Pentecost, It Works! CEO and entrepreneur, advocates for philanthropy now more than ever as communities look to…
Author: admin
Chubb Introduces New and Modernized Package Product for Commercial Clients
Chubb has introduced a new insurance product, Benchmarq Package, for the lower middle market segment, setting…
Clinical Trial Application of ASC40 Combined with Bevacizumab to Treat Patients with Recurrent Glioblastoma Accepted by China NMPA
Ascletis Pharma Inc. (HKEX code: 1672) today announces that following the consultation with China National Medical…
HEALTHdrum’s Digital Health Platform Challenges Sick Healthcare System
HEALTHdrum.com LLC, a Boca Raton healthcare technology company, announced today the launch of their cost-transparent healthcare marketplace platform…
amg International GmbH, a Q3 Medical Devices Ltd Company,
amg International GmbH (“amg” or the “Company”), a wholly owned subsidiary of Dublin, Ireland based Q3 Medical Devices…
Novavax to Present at International Society for Vaccines Virtual Congress COVID-19 Vaccine Update
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that Gregory…
Tivity Health to Participate in Upcoming Investor Conferences
Tivity Health, Inc. (NASDAQ: TVTY) today announced that it will participate in the following virtual investor conferences:…
Seelos Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central…
Oncopeptides presents clinical abstracts on melflufen at the 2021 American Society of Clinical Oncology
Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies…
Novartis to unveil new data at ASCO and EHA from its robust portfolio
Novartis will present new data from its portfolio of approved and investigational targeted, radioligand, cell and…